Clinical Trials Directory

Trials / Conditions / Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8

Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8

16 registered clinical trials studyying Clinical Stage IVA Gastroesophageal Junction Adenocarcinoma AJCC v8 — 5 currently recruiting.

StatusTrialSponsorPhase
WithdrawnNeoadjuvant Therapy for the Treatment of Gastroesophageal Junction and Gastric Cancers
NCT05296005
Ohio State University Comprehensive Cancer CenterPhase 1
Active Not RecruitingTesting Immunotherapy (Atezolizumab) With or Without Chemotherapy in Locoregional MSI-H/dMMR Gastric and Gastr
NCT05836584
National Cancer Institute (NCI)Phase 2
RecruitingPersonalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Soli
NCT05269381
Mayo ClinicPhase 1 / Phase 2
RecruitingPembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adeno
NCT05041153
M.D. Anderson Cancer CenterEARLY_Phase 1
Active Not RecruitingChemoradiation and Pembrolizumab Followed by Pembrolizumab and Lenvatinib Before Surgery for the Treatment of
NCT04929392
City of Hope Medical CenterPhase 2
RecruitingRamucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Adv
NCT04660760
Academic and Community Cancer Research UnitedPhase 2
Active Not RecruitingTesting the Addition of an Anti-cancer Drug, Adavosertib, to Radiation Therapy for Patients With Incurable Eso
NCT04460937
National Cancer Institute (NCI)Phase 1
RecruitingAvapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Sol
NCT04771520
M.D. Anderson Cancer CenterPhase 2
Active Not RecruitingPembrolizumab and Chemoradiotherapy for the Treatment of Unresectable Gastroesophageal Cancer
NCT04522336
M.D. Anderson Cancer CenterPhase 1
CompletedUse of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esopha
NCT04097028
Roswell Park Cancer InstitutePhase 2
Active Not RecruitingPaclitaxel for the Treatment of Gastric or Gastroesophageal Cancer
NCT04220827
M.D. Anderson Cancer CenterPhase 1
CompletedGenetic Analysis of Blood and Tissue Samples From Patients With Advanced Cancer, Moonshot Study
NCT03707574
National Cancer Institute (NCI)—
RecruitingComparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer
NCT03801876
NRG OncologyPhase 3
SuspendedNivolumab and Ipilimumab in Treating Patients With Esophageal and Gastroesophageal Junction Adenocarcinoma Und
NCT03604991
National Cancer Institute (NCI)Phase 2 / Phase 3
CompletedIRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Ga
NCT03918499
City of Hope Medical CenterPhase 1 / Phase 2
Active Not RecruitingNivolumab, Ipilimumab and Chemoradiation in Treating Patients With Resectable Gastric Cancer
NCT03776487
M.D. Anderson Cancer CenterPhase 2